Clinical Trial Update: Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of thalidomide and prednisone after peripheral stem cell transplantation for multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• PREDNISONE (Prednisone)
• Thalidomide (thalidomide)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED